000 01548 a2200421 4500
005 20250517074310.0
264 0 _c20161104
008 201611s 0 0 eng d
022 _a1557-7422
024 7 _a10.1089/hum.2015.137
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCavazzana, Marina
245 0 0 _aGene Therapy for X-Linked Severe Combined Immunodeficiency: Where Do We Stand?
_h[electronic resource]
260 _bHuman gene therapy
_cFeb 2016
300 _a108-16 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aB-Lymphocytes
_ximmunology
650 0 4 _aClinical Trials as Topic
650 0 4 _aGammaretrovirus
_xgenetics
650 0 4 _aGenetic Therapy
_xmethods
650 0 4 _aGenetic Vectors
_xchemistry
650 0 4 _aHematopoietic Stem Cell Transplantation
650 0 4 _aHematopoietic Stem Cells
_xcytology
650 0 4 _aHumans
650 0 4 _aKiller Cells, Natural
_ximmunology
650 0 4 _aLentivirus
_xgenetics
650 0 4 _aPatient Safety
650 0 4 _aRetroviridae
_xgenetics
650 0 4 _aT-Lymphocytes
_ximmunology
650 0 4 _aVirus Integration
_xgenetics
650 0 4 _aX-Linked Combined Immunodeficiency Diseases
_xgenetics
700 1 _aSix, Emmanuelle
700 1 _aLagresle-Peyrou, Chantal
700 1 _aAndré-Schmutz, Isabelle
700 1 _aHacein-Bey-Abina, Salima
773 0 _tHuman gene therapy
_gvol. 27
_gno. 2
_gp. 108-16
856 4 0 _uhttps://doi.org/10.1089/hum.2015.137
_zAvailable from publisher's website
999 _c25651245
_d25651245